DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+13.41%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.21B
AUM Growth
+$2.21B
(+22%)
Cap. Flow
+$176M
Cap. Flow
% of AUM
7.94%
Top 10 Holdings %
Top 10 Hldgs %
38.16%
Holding
100
New
15
Increased
24
Reduced
25
Closed
9
Top Buys
| 1 |
McKesson
MCK
|
$63.5M |
| 2 |
DexCom
DXCM
|
$57.3M |
| 3 |
Viatris
VTRS
|
$56M |
| 4 |
Glaukos
GKOS
|
$53.9M |
| 5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$46.5M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$73.6M |
| 2 |
Gilead Sciences
GILD
|
$66.4M |
| 3 |
NXTM
NxStage Medical Inc.
NXTM
|
$62.2M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$28M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$26.4M |
Sector Composition
| 1 | Healthcare | 76.44% |
| 2 | Financials | 0.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
76
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.86M | 0.08% |
+118,116
| New | +$1.86M |
|
77
MiMedx Group
MDXG
$1.05B
| $1.78M | 0.08% |
+150,000
| New | +$1.78M |
|
|
RARX
78
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.49M | 0.07% |
102,150
+19,557
| +24% | +$285K |
|
|
AET
79
DELISTED
Aetna Inc
AET
| – | – |
-130,000
| Closed | -$19.7M |
|
|
JNCE
80
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| – | – |
-247,872
| Closed | -$3.48M |
|
|
KA
81
DELISTED
Kineta, Inc. Common Stock
KA
| – | – |
-123
| Closed | -$81K |
|
|
NVRO
82
DELISTED
NEVRO CORP.
NVRO
| – | – |
-376,308
| Closed | -$28M |
|
83
Zevra Therapeutics
ZVRA
$501M
| – | – |
-44,038
| Closed | -$2.82M |
|
84
Puma Biotechnology
PBYI
$258M
| – | – |
0
| – | – |
|
85
MannKind Corp
MNKD
$1.69B
| – | – |
-2,702,403
| Closed | -$3.81M |
|
|
86
Gilead Sciences
GILD
$140B
| – | – |
-938,515
| Closed | -$66.4M |
|
87
ESSA Pharma
EPIX
$11.2M
| – | – |
-70,812
| Closed | -$779K |
|
88
Elevance Health
ELV
$72.4B
| – | – |
-75,182
| Closed | -$14.1M |
|